Search Results - "Tursi, James P."

The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study by Gaston, R. Glenn, MD, Larsen, Søren Erik, MD, Pess, Gary M., MD, Coleman, Stephen, MBBS, Dean, Brian, MS, Cohen, Brian M., PhD, Kaufman, Gregory J., MD, Tursi, James P., MD, Hurst, Lawrence C., MD

“…Purpose To evaluate efficacy and safety of concurrent administration of 2 collagenase clostridium histolyticum (CCH) injections to treat 2 joints in the same…”
Get full text

Dupuytren Contracture Recurrence Following Treatment with Collagenase Clostridium Histolyticum (CORDLESS Study): 3-Year Data by Peimer, Clayton A., MD, Blazar, Philip, MD, Coleman, Stephen, MBBS, Kaplan, F. Thomas D., MD, Smith, Ted, PhD, Tursi, James P., MD, Cohen, Brian, PhD, Kaufman, Gregory J., MD, Lindau, Tommy, MD, PhD

“…Purpose To evaluate long-term efficacy and safety of collagenase clostridium histolyticum (CCH) after the third year of a 5-year nontreatment follow-up study,…”
Get full text

Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for Multiple Dupuytren Contractures by Coleman, Stephen, MBBS, Gilpin, David, MBBS, Kaplan, F. Thomas D., MD, Houston, Anthony, MBBS, Kaufman, Gregory J., MD, Cohen, Brian M., PhD, Jones, Nigel, BSc, Tursi, James P., MD

“…Purpose To assess the safety and efficacy of 2 concurrent injections of collagenase clostridium histolyticum (CCH) in the same hand to treat multiple Dupuytren…”
Get full text

Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum by Bear, Brian J., MD, Peimer, Clayton A., MD, Kaplan, F. Thomas D., MD, Kaufman, Gregory J., MD, Tursi, James P., MD, Smith, Ted, PhD

“…Purpose Collagenase Clostridium histolyticum (CCH) is approved for the treatment of adults with Dupuytren contracture with a palpable cord. This open-label,…”
Get full text

Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double‐blind, randomized, placebo‐controlled, phase III studies by Lipshultz, Larry I., Goldstein, Irwin, Seftel, Allen D., Kaufman, Gregory J., Smith, Ted M., Tursi, James P., Burnett, Arthur L.

“…Objectives To examine the efficacy of intralesional collagenase Clostridium histolyticum (CCH) in defined subgroups of patients with Peyronie's disease (PD)…”
Get full text

Clinical Safety and Effectiveness of Collagenase Clostridium Histolyticum Injection in Patients with Peyronie's Disease: A Phase 3 Open‐Label Study by Levine, Laurence A., Cuzin, Beatrice, Mark, Stephen, Gelbard, Martin K., Jones, Nigel A., Liu, Genzhou, Kaufman, Gregory J., Tursi, James P., Ralph, David J.

“…Collagenase clostridium histolyticum (CCH; Xiaflex, Auxilium Pharmaceuticals, Inc., Chesterbrook, PA, USA) is a Food and Drug Administration‐approved,…”
Get full text

Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD) by Carson, Culley C., Sadeghi‐Nejad, Hossein, Tursi, James P., Smith, Ted M., Kaufman, Gregory J., Gilbert, Kimberly, Honig, Stanton C.

“…Objective To examine the safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for the treatment of Peyronie's disease (PD), using a…”
Get full text

Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach by Gelbard, Martin K., Chagan, Larisa, Tursi, James P.

“…The conception of collagenase Clostridium histolyticum (CCH) as treatment for Peyronie's disease (PD) was a vital first step in providing a nonsurgical,…”
Get full text

Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age by Pastuszak, Alexander W., Gittelman, Marc, Tursi, James P., Jaffe, Jonathan S., Schofield, David, Miner, Martin M.

“…Background To improve symptoms associated with testosterone deficiency, many testosterone therapies are available that aim to restore serum testosterone (T)…”
Get full text

Testosterone Use in Adolescent Males: Current Practice and Unmet Needs by Vogiatzi, Maria, Tursi, James P, Jaffe, Jonathan S, Hobson, Sue, Rogol, Alan D

“…Abstract Testosterone replacement therapy (TRT) is routinely prescribed in adolescent males with constitutional delay of growth and puberty (CDGP) or…”
Get full text

Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study by Hellstrom, Wayne J.G, Kaminetsky, Jed, Belkoff, Laurence H, Goldstein, Irwin, Tursi, James P, Uy, Jonathan, Peterson, Craig A, Bowden, Charles H, Day, Wesley W

“…Purpose We examined the therapeutic effects of avanafil 15 minutes after dosing in men with mild to severe erectile dysfunction. Materials and Methods This…”
Get full text

Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies by Hellstrom, Wayne J.G, Feldman, Robert A, Coyne, Karin S, Kaufman, Gregory J, Smith, Ted M, Tursi, James P, Rosen, Raymond C

“…Objective To evaluate the clinical usefulness of the Peyronie's Disease Questionnaire (PDQ). The relationship between subject-reported changes in PDQ…”
Get full text

PD45-12 AVANAFIL EFFICACY WITHIN 15 MINUTES OF DOSING IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION BY DEMOGRAPHIC AND BASELINE CLINICAL CHARACTERISTICS by Belkoff, Laurence H, Tursi, James P, Uy, Jonathan, Smith, Ted M, Jones, LeRoy A

Get full text

Postapproval Clinical Experience in the Treatment of Dupuytren's Contracture with Collagenase Clostridium Histolyticum (CCH): The First 1,000 Days by Schulze, Scott M., Tursi, James P.

“…Dupuytren's contracture is a benign fibromatosis of the palmar and digital fascia of the hand of uncertain etiology, resulting in nodules and cords beneath the…”
Get full text

PD48-06 OUTCOMES ASSOCIATED WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENT FOR PEYRONIE'S DISEASE BY DURATION OF DISEASE by Levine, Laurence A, Gelbard, Martin K, Tursi, James P, Smith, Ted M, Kaufman, Gregory J, Gilbert, Kimberly, Kaminetsky, Jed, Mulhall, John P

Get full text

The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events by Zhang, Wenjie, Han, Yi, Fort, John G, Schofield, David, Tursi, James P

“…Aspirin (acetylsalicylic acid; ASA) is commonly used for secondary prevention of cardiovascular (CV) events, but may be associated with gastrointestinal (GI)…”
Get more information

PD48-07 CHANGES IN THE EFFECTS OF PEYRONIE'S DISEASE AFTER TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM ACCORDING TO MEN WITH PEYRONIE'S DISEASE AND THEIR FEMALE SEXUAL PARTNERS by Goldstein, Irwin, Knoll, Dean, Lipshultz, Larry I, Tursi, James P, Smith, Ted M, Kaufman, Gregory J, Gilbert, Kimberly, Rosen, Raymond C, McMahon, Chris G

Get full text

Effect of Baseline Severity on the Safety and Efficacy of Concurrent Collagenase Clostridium Histolyticum Injections to Treat 2 Dupuytren Contractures by Verheyden, James R., MD, Freyne, Brigid, MD, Frazier, Joel L., MD, Kaufman, Gregory J., MD, Tursi, James P., MD, Smith, Ted, PhD

Get full text

Treatment of Recurrent Dupuytren Contractures in Joints Previously Effectively Treated With Collagenase Clostridium Histolyticum: Final Results by Peimer, Clayton A., MD, Bainbridge, Lionel Chris, FRCS, Wilbrand, Stephan, MD, Dean, Brian, MS, Tursi, James P., MD, Smith, Ted, PhD

Get full text

Prospective Multicenter, Multinational Study to Evaluate the Safety and Efficacy of Concurrent Collagenase Clostridium Histolyticum Injections to Concurrently Treat 2 Dupuytren Contractures in the Same Hand by Hurst, Lawrence, MD, Gaston, R Glenn, MD, Brown, Richard A., MD, Kaufman, Gregory J., MD, Tursi, James P., MD, Smith, Ted, PhD

Get full text